Skip to Content

Investor to oppose Quipt board nominees

Investor to oppose Quipt board nominees

NEW YORK – Philotimo Fund, LP, an entity affiliated with Kanen Wealth Management, LLC and David L. Kanen filed notice with the U.S. Securities and Exchange Commission on Jan. 25 that it intends to oppose Quipt Home Medical’s four director candidates to the board and solicit proxies in support of four other director candidates. Philotimo stated its intention to solicit proxies for the election of Selim Bassoul, Jack Feidor, Garrett Larson and Edward Smith as nominees to be elected to the board at the Annual Meeting on March 17. Quipt’s four director candidates are Gregory Crawford, CEO of the company; Mark Greenberg; Kevin Carter; and Brian Wessel. The filing was made pursuant to Rule 14a-19(b) under the Exchange Act. In addition to satisfying the SEC’s universal proxy rules, the purported nominating shareholder must also comply with the advance notice requirements to nominate a candidate for election to the board. 

Comments

To comment on this post, please log in to your account or set up an account now.